Overview

Overview

In this section you can find all materials related to our financial reporting

Latest Annual Report (20-F)

Latest Annual Report (German)

Here you will find our latest German annual report going forward once we have filed our first report in 2020

Latest Quarterly Report

Show all

Latest SEC Filings

Filing date Description Form View

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

 6-K View HTML
0001564590-20-024741.pdf
0001564590-20-024741.rtf
0001564590-20-024741.xls

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

 6-K View HTML
0001193125-20-134949.pdf
0001193125-20-134949.rtf
0001193125-20-134949.xls

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

 6-K View HTML
0001564590-20-020990.pdf
0001564590-20-020990.rtf
0001564590-20-020990.xls

Toolkit

Media Contact Jasmina Alatovic
Senior Manager Global External Communications
Media@biontech.de
+49 6131 9084-1513
Investor Contact Sylke Maas, Ph.D.
VP Investor Relations & Business Strategy
Investors@biontech.de
+49 6131 9084-074
For U.S. Investors:
Westwicke
Victoria Meissner, M.D.
victoria.meissner@westwicke.com
+1 646 677-1837
Whistleblower Hotline BioNTech Hotline (anonymous)
Germany: 0800 000-8972
US: 844 901-0271
Other: +1 757 278-0107
Online Access to Whistle Blowing Reporting
Or by Email